2017-07-30T02:25:24+03:00[Europe/Moscow] en true Sandhoff disease, Sphingolipidoses, Cerebrotendineous xanthomatosis, Canavan disease, GM2-gangliosidosis, AB variant, GM1 gangliosidoses, GM2 gangliosidoses, Tay–Sachs disease, Batten disease, Jansky–Bielschowsky disease, Infantile neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis, Farber disease, Niemann–Pick disease, Niemann–Pick disease, type C, Gaucher's disease, Metachromatic leukodystrophy, Multiple sulfatase deficiency, Krabbe disease, Fabry disease, Gangliosidosis, Sulfatidosis, Pelizaeus–Merzbacher disease, Schindler disease, Niemann–Pick disease, SMPD1-associated, Lysosomal acid lipase deficiency flashcards
Lipid storage disorders

Lipid storage disorders

  • Sandhoff disease
    Sandhoff disease, also known as Sandhoff-Jatzkewitz disease, variant 0 of GM2-Gangliosidosis or Hexosaminidase A and B deficiency, is a lysosomal genetic, lipid storage disorder caused by the inherited deficiency to create functional beta-hexosaminidases A and B.
  • Sphingolipidoses
    Sphingolipidoses (singular "sphingolipidosis") are a class of lipid storage disorders relating to sphingolipid metabolism.
  • Cerebrotendineous xanthomatosis
    Cerebrotendineous xanthomatosis or cerebrotendinous xanthomatosis (CTX), also called cerebral cholesterosis, is an autosomal recessive form of xanthomatosis.
  • Canavan disease
    Canavan disease, also called Canavan-Van Bogaert-Bertrand disease, is an autosomal recessive degenerative disorder that causes progressive damage to nerve cells in the brain, and is one of the most common degenerative cerebral diseases of infancy.
  • GM2-gangliosidosis, AB variant
    GM2-gangliosidosis, AB variant is a rare, autosomal recessive metabolic disorder that causes progressive destruction of nerve cells in the brain and spinal cord.
  • GM1 gangliosidoses
    The GM1 gangliosidoses are caused by a deficiency of beta-galactosidase, with resulting abnormal storage of acidic lipid materials in cells of the central and peripheral nervous systems, but particularly in the nerve cells.
  • GM2 gangliosidoses
    The GM2 gangliosidoses are a group of three related genetic disorders that result from a deficiency of the enzyme beta-hexosaminidase.
  • Tay–Sachs disease
    Tay–Sachs disease (also known as GM2 gangliosidosis or hexosaminidase A deficiency) is a rare autosomal recessive genetic disorder.
  • Batten disease
    Batten disease is an extremely rare and fatal autosomal recessive neurodegenerative disorder that begins in childhood.
  • Jansky–Bielschowsky disease
    Jansky–Bielschowsky disease is an extremely rare autosomal recessive genetic disorder that is part of the neuronal ceroid lipofuscinosis (NCL) family of neurodegenerative disorders.
  • Infantile neuronal ceroid lipofuscinosis
    Infantile neuronal ceroid lipofuscinoses (INCL) or Santavuori disease is a form of NCL and inherited as a recessive autosomal genetic trait.
  • Neuronal ceroid lipofuscinosis
    Neuronal ceroid lipofuscinosis (NCL) is the general name for a family of at least eight genetically separate neurodegenerative disorders that result from excessive accumulation of lipopigments (lipofuscin) in the body's tissues.
  • Farber disease
    Farber disease (also known as Farber's lipogranulomatosis, ceramidase deficiency, "Fibrocytic dysmucopolysaccharidosis," and "Lipogranulomatosis") is an extremely rare (80 cases reported worldwide to this day) autosomal recessive lysosomal storage disease marked by a deficiency in the enzyme ceramidase that causes an accumulation of fatty material sphingolipids leading to abnormalities in the joints, liver, throat, tissues and central nervous system.
  • Niemann–Pick disease
    Niemann–Pick disease (/niːmənˈpɪk/ nee-mən-PIK) is a group of inherited, severe metabolic disorders in which sphingomyelin accumulates in lysosomes in cells.
  • Niemann–Pick disease, type C
    Niemann–Pick type C is a lysosomal storage disease associated with mutations in NPC1 and NPC2 genes.
  • Gaucher's disease
    Gaucher's disease or Gaucher disease (/ɡoʊˈʃeɪ/) (GD) is a genetic disorder in which glucocerebroside (a sphingolipid, also known as glucosylceramide) accumulates in cells and certain organs.
  • Metachromatic leukodystrophy
    Metachromatic leukodystrophy (MLD, also called Arylsulfatase A deficiency) is a lysosomal storage disease which is commonly listed in the family of leukodystrophies as well as among the sphingolipidoses as it affects the metabolism of sphingolipids.
  • Multiple sulfatase deficiency
    Multiple sulfatase deficiency (also known as "Austin disease," and "Mucosulfatidosis") is a very rare autosomal recessive lysosomal storage disease caused by a deficiency in multiple sulfatase enzymes, or in formylglycine-generating enzyme, which activates sulfatases.
  • Krabbe disease
    Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system.
  • Fabry disease
    Fabry disease (/ˈfɑːbri/) (also known as Fabry's disease, Anderson-Fabry disease, angiokeratoma corporis diffusum, and alpha-galactosidase A deficiency) is a rare genetic lysosomal storage disease, inherited in an X-linked manner.
  • Gangliosidosis
    Gangliosidosis is a sub-category of Sphingolipidosis that contains two different types of lipid storage disorders caused by the accumulation of lipids known as gangliosides.
  • Sulfatidosis
    Sulfatidosis is a form of lysosomal storage disease resulting in a proliferation of sulfatide.
  • Pelizaeus–Merzbacher disease
    Pelizaeus–Merzbacher disease (PMD) is a rare central nervous system disorder in which coordination, motor abilities, and intellectual function are delayed to variable extents.
  • Schindler disease
    Schindler disease, also known as Kanzaki disease and alpha-N-acetylgalactosaminidase deficiency is a rare disease found in humans.
  • Niemann–Pick disease, SMPD1-associated
    Niemann–Pick disease, SMPD1-associated refers to two different types of Niemann–Pick disease which are associated with the SMPD1 gene.
  • Lysosomal acid lipase deficiency
    Lysosomal acid lipase deficiency (or LAL deficiency or LAL-D) happens when the body does not produce enough active lysosomal acid lipase (LAL) enzyme.